Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Renovaro BioSciences Inc (RENB)

  • Technical Exchange News
  • Sept. 09, 2025, 00:53 UTC
  • 2
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Renovaro Inc. - Common Stock. New value: Lunai Bioworks Inc. - Common Stock.

Comment Full text

Nektar Therapeutics (NKTR)

  • SEC News
  • Sept. 09, 2025, 00:32 UTC
  • 4
  • 1 comments

Zalevsky Jonathan 🔴 sold 1.7K shares of NEKTAR THERAPEUTICS (NKTR) at $35.69 Transaction Date: Sep 04, 2025 | Filing ID: 113692

Comment Full text

Nektar Therapeutics (NKTR)

  • SEC News
  • Sept. 09, 2025, 00:31 UTC
  • 4
  • 1 comments

ROBIN HOWARD W 🔴 sold 11.8K shares of NEKTAR THERAPEUTICS (NKTR) at $39.89 Transaction Date: Sep 04, 2025 | Filing ID: 113691

Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • SEC News
  • Sept. 09, 2025, 00:20 UTC
  • 5
  • 1 comments

Cannon Gillian 🟡 adjusted position in 3.6K shares (1 derivative) of CORCEPT THERAPEUTICS INC (CORT) at $70.13 Transaction Date: Sep 04, 2025 | Filing ID: 198568

Comment Full text

HCA Holdings Inc (HCA)

  • SEC News
  • Sept. 09, 2025, 00:16 UTC
  • 4
  • 0 comments

New Form 144 - HCA Healthcare, Inc. Filed: 2025-09-08 AccNo: 0001965353-25-000161 Size: 5 KB

Comment Full text

Mineralys Therapeutics Inc (MLYS)

  • SEC News
  • Sept. 09, 2025, 00:07 UTC
  • 5
  • 1 comments

AKKARAJU SRINIVAS 🟢 acquired 588.2K shares of Mineralys Therapeutics, Inc. (MLYS) at $25.50 ($15.0M) Transaction Date: Sep 04, 2025 | Filing ID: 023919

Comment Full text

Amgen Inc (AMGN)

  • Business News
  • Sept. 09, 2025, 00:06 UTC
  • 5
  • 0 comments

AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Market reaction Comment Full text

Mineralys Therapeutics Inc (MLYS)

  • SEC News
  • Sept. 09, 2025, 00:06 UTC
  • 4
  • 0 comments

New Form SCHEDULE 13D/A - Mineralys Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001415889-25-023916 Size: 21 KB

Comment Full text

Penumbra Inc (PEN)

  • Business News
  • Sept. 08, 2025, 23:55 UTC
  • 2
  • 0 comments

Lightning Bolt 6X with Trax Now Available in 150 cm, Bringing the Power of CAVT to More Distal Anatomy Below the Knee

Market reaction Comment Full text

Bespoke Extracts, Inc. (BSPK)

  • SEC News
  • Sept. 08, 2025, 23:53 UTC
  • 4
  • 1 comments

Director FEINSOD MICHAEL 🟢 acquired 2.5K shares of Bespoke Extracts, Inc. (BSPK) at $0.19 Transaction Date: Sep 08, 2025 | Filing ID: 085745

Comment Full text

Penumbra Inc (PEN)

  • Business News
  • Sept. 08, 2025, 23:44 UTC
  • 1
  • 0 comments

Get Out the Clot Survey Identifies Gaps in Blood Clot Care

Market reaction Comment Full text

Aquestive Therapeutics Inc (AQST)

  • SEC News
  • Sept. 08, 2025, 23:06 UTC
  • 4
  • 1 comments

Jung Cassie 🟡 adjusted position in 62.2K shares (2 derivative) of Aquestive Therapeutics, Inc. (AQST) at $5.00 Transaction Date: Sep 04, 2025 | Filing ID: 013493

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Sept. 08, 2025, 23:02 UTC
  • 4
  • 0 comments

Annual Reports and Related Documents:

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Sept. 08, 2025, 23:01 UTC
  • 2
  • 0 comments

Mandatory Cash Dividend/ Distribution:

Comment Full text

HC Surgical Specialists Limited (1B1)

  • SEC News
  • Sept. 08, 2025, 23:00 UTC
  • 1
  • 0 comments

Annual Reports and Related Documents:

Comment Full text
  • Previous
  • 78
  • 79
  • 80
  • 81
  • 82
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169702)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112980)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin